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Abstract
Background: Granulomatous amoebic encephalitis due to Acanthamoeba is often a fatal human
disease. However, the pathogenesis and pathophysiology of Acanthamoeba encephalitis remain
unclear. In this study, the role of extracellular Acanthamoeba proteases in central nervous system
pathogenesis and pathophysiology was examined.
Results: Using an encephalitis isolate belonging to T1 genotype, we observed two major proteases
with approximate molecular weights of 150 KD and 130 KD on SDS-PAGE gels using gelatin as
substrate. The 130 KD protease was inhibited with phenylmethylsulfonyl fluoride (PMSF) suggesting
that it is a serine protease, while the 150 KD protease was inhibited with 1, 10-phenanthroline
suggesting that it is a metalloprotease. Both proteases exhibited maximal activity at neutral pH and
over a range of temperatures, indicating their physiological relevance. These proteases degrade
extracellular matrix (ECM), which provide structural and functional support to the brain tissue, as
shown by the degradation of collagen I and III (major components of collagenous ECM), elastin
(elastic fibrils of ECM), plasminogen (involved in proteolytic degradation of ECM), as well as casein
and haemoglobin. The proteases were purified partially using ion-exchange chromatography and
their effects were tested in an in vitro model of the blood-brain barrier using human brain
microvascular endothelial cells (HBMEC). Neither the serine nor the metalloprotease exhibited
HBMEC cytotoxicity. However, the serine protease exhibited HBMEC monolayer disruptions
(trypsin-like) suggesting a role in blood-brain barrier perturbations.
Conclusion: Overall, these data suggest that Acanthamoeba proteases digest ECM, which may play
crucial role(s) in invasion of the brain tissue by amoebae.
Background
Acanthamoeba  are opportunistic protozoans that are
widely distributed in the environment. Given the oppor-
tunity and the host immune status, pathogenic Acan-
thamoeba can invade the human central nervous system
(CNS) and produce fatal granulomatous encephalitis [1-
4].  Acanthamoeba  granulomatous encephalitis (AGE) is
characterized by headache, fever, behavioural changes,
Published: 03 May 2006
BMC Microbiology2006, 6:42 doi:10.1186/1471-2180-6-42
Received: 15 March 2006
Accepted: 03 May 2006
This article is available from: http://www.biomedcentral.com/1471-2180/6/42
© 2006Sissons et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Microbiology 2006, 6:42 http://www.biomedcentral.com/1471-2180/6/42
Page 2 of 8
(page number not for citation purposes)
hemiparesis, lethargy, stiff neck, aphasia, ataxia, vomiting,
nausea, cranial nerve palsies, increased intracranial pres-
sure, seizures and ultimately death. Death is due to haem-
orrhaging necrotic lesions with severe meningeal
irritation and encephalitis. The lesions due to AGE are
most numerous in the basal ganglia, midbrain, brainstem,
and cerebral hemispheres with characteristic lesions in the
CNS parenchyma resulting in chronic granulomatous
encephalitis.
The mechanisms associated with the pathogenesis of AGE
remain incompletely understood, however the patho-
physiological complications involving the CNS most
likely include induction of the pro-inflammatory
responses, invasion of the blood-brain barrier and the
connective tissue and neuronal damage leading to the
brain dysfunction [1-4]. The routes of entry include lower
respiratory tract leading to amoebae invasion of the intra-
vascular space, followed by the haematogenous spread.
Skin lesions may provide direct amoebae entry into the
bloodstream, thus bypassing the lower respiratory tract.
Amoebae entry into the CNS most likely occurs at the sites
of the blood-brain barrier [1,2]. In addition, olfactory
neuroepithelium provides another route of entry into the
CNS and has been studied in experimental models [1,2].
Following CNS invasion, amoebae penetrate the brain tis-
sue to produce disease. Previous studies have shown that
proteases play important roles in microbial pathogenesis
including host cell and tissue invasion, migration, catabo-
lism of host proteins, cytoadherence, and both stimula-
tion and evasion of host responses [reviewed in [7]]. The
present study examines Acanthamoeba proteases released
extracellularly by an AGE isolate to begin to ask if these
proteases could be involved in this amoeba's ability to
invade the CNS. Our studies are feasible with the availa-
bility of the in vitro cultures of the human brain microvas-
cular endothelial cells, which constitute the blood-brain
barrier. Here, we report that proteases from an AGE isolate
of  Acanthamoeba  digest ECM and produce blood-brain
barrier disruptions and thus may play crucial role(s) in
invasion of the brain tissue by amoebae.
Results
Acanthamoeba keratitis isolate (T4 genotype) exhibited 
two serine proteases while AGE isolate (T1 genotype) 
exhibited one serine and one metalloprotease
To determine the extracellular proteases of Acanthamoeba,
conditioned medium (CM) was used for zymographic
assays. Acanthamoeba keratitis isolate (T4 genotype) exhib-
ited two protease bands observed at approximate molecu-
lar weights (Mw) of 130 KD and 85 KD (Fig. 1A).
However, both protease bands were sensitive to PMSF
indicating that Acanthamoeba secrete serine proteases, a
finding that is consistent with previous studies (reviewed
in [5]). Thus, the remaining studies have been focused on
the AGE isolate. In contrast, AGE isolate (T1 genotype)
exhibited a 150 KD metalloprotease (inhibited with 1, 10-
phenanthroline) and a 130 KD serine protease (inhibited
by PMSF) (Fig. 1B). Of interest, CM produced from co-cul-
tures of Acanthamoeba and HBMEC exhibited similar pro-
tease profiles (data not shown).
Acanthamoeba extracellular protease profiles of T1 (AGE iso- late) and T4 (AK isolate) Figure 1
Acanthamoeba extracellular protease profiles of T1 
(AGE isolate) and T4 (AK isolate). Conditioned medium 
(CM) from T1 and T4 isolates was collected and used for 
zymography as described in "Materials and Methods". CM + 
PMSF or CM + 1, 10-phenathroline means that the CM was 
incubated with these protease inhibitors prior to electro-
phoresis and in the case of 1, 10 phenanthroline it was also 
included in the developing buffer. Note that AK isolate (T4 
genotype) exhibited two serine proteases of approx. Mw. of 
85 KD and 130 KD that were inhibited with PMSF, i.e., serine 
protease inhibitor. In contrast, AGE isolate exhibited one 
serine protease at approx. Mw. 130 KD and a 150 KD metal-
loprotease sensitive to 1, 10-phenanthroline, i.e., metallopro-
tease inhibitor. Results are representative of three 
independent experiments.BMC Microbiology 2006, 6:42 http://www.biomedcentral.com/1471-2180/6/42
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Conditioned medium of the AGE isolate exhibited HBMEC 
monolayer disruptions but not cytotoxicity
To determine the cytopathic effects of extracellular pro-
teases of AGE isolate (T1 genotype), cytotoxicity assays
were performed. Hematoxylin staining of HBMEC monol-
ayers revealed that the AGE isolate as well as its CM pro-
duced total HBMEC monolayer disruptions (Fig. 2A and
2B). The CM-mediated HBMEC monolayer disruptions
were completely abolished after pre-incubating the CM
with PMSF (Fig. 2A and 2B). Pre-incubations with broad
spectrum matrix metalloprotease (MMP) inhibitors, i.e.,
GM 1489 or GM 6001, had no effect on CM-mediated
HBMEC monolayer disruptions (Fig. 2A and 2B). The
AGE isolate produced more than 70% HBMEC cytotoxic-
ity, while its CM exhibited minimal HBMEC cytotoxicity
(Fig. 2C). Furthermore, neither broad spectrum MMP
inhibitors had an effect on AGE isolate-mediated HBMEC
cytotoxicity (data not shown). Similar findings were
observed with AK isolate belonging to T4 genotype (data
not shown). Taken together, these data demonstrate that
130 KD serine protease (but not the 150 KD metallopro-
tease) produced HBMEC monolayer disruptions but not
HBMEC cytotoxicity.
The effect of various temperatures and pH on the 
extracellular proteases of AGE isolate
To determine the physiological properties of extracellular
proteases of AGE isolate (T1 genotype), zymographic
assays were performed using gelatin as substrate and gels
incubated at various temperatures and pH. The results
revealed that both serine and metalloproteases exhibited
optimal activities at neutral pH (Fig. 3). The influence of
various temperatures on the proteolytic activities was
tested in the temperature intervals from 4°C – 65°C. The
optimal activity was observed at temperatures varying
from 37°C – 50°C (Fig. 4), indicating that proteases are
also active at physiologically relevant conditions. Of inter-
est, the metalloprotease (approx. Mw. 150 KD) visually
appeared to have lost significant activity in zymography
during incubation at 65°C (Fig. 4).
Both serine (130 KD) and metalloproteases (150 KD) of 
AGE isolate exhibited collagenase and elastinolytic 
activities
The fibrillary collagens and elastin are structural proteins
that are the major components of the ECM. To determine
the ability of serine and metalloproteases to exhibit colla-
genase activities, zymographic assays were performed
using collagen I and III as substrates. Both serine and met-
alloproteases degraded collagen I and III substrates (Fig.
5) confirming their collagenase activities. Additionally,
both proteases degraded elastin (a major constituent of
elastic fibers) in the zymographic assays, indicating that
proteases from AGE isolate exhibit elastinolytic activities
(Fig. 5). Among other substrates, these proteases exhibited
degradation of casein and haemoglobin (Fig. 5).
A) Conditioned medium (CM) of the AGE isolate exhibited  HBMEC monolayer disruptions Figure 2
A) Conditioned medium (CM) of the AGE isolate 
exhibited HBMEC monolayer disruptions. Acan-
thamoeba (AGE isolate belonging to T1 genotype) or their 
CM were added to human brain microvascular endothelial 
cells (HBMEC) monolayers as described in "Materials and 
Methods". A) HBMEC monolayers were stained with hema-
toxylin to observe monolayer disruptions. HBMEC alone 
represent HBMEC without parasites and/or CM and were 
used as controls. Both Acanthamoeba as well as CM exhibited 
HBMEC monolayer disruptions. Note that PMSF blocked 
CM-mediated HBMEC monolayer disruptions. In contrast, 
metalloprotease inhibitors (GM 1489 and GM 6001) had no 
effects on CM-mediated HBMEC monolayer disruptions. B) 
Micrography of HBMEC cytopathic effects. Micrographs 
were taken using a phase-contrast microscope, ×200. C) CM 
of the AGE isolate did not produce HBMEC cytotoxicity. 
Note that Acanthamoeba (AGE isolate belonging to T1 geno-
type) exhibited more than 70% HBMEC cytotoxicity, while 
their CM induced less than 10% HBMEC cytotoxicity. Results 
are mean of three experiments performed in duplicates. 
Error bars represent standard error.BMC Microbiology 2006, 6:42 http://www.biomedcentral.com/1471-2180/6/42
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Both serine (130 KD) and metalloproteases (150 KD) of 
AGE isolate degrade plasminogen
Other modes of ECM degradation are tissue-type and
urokinase-type plasminogen activators. The former path-
way is mostly involved in fibrinolysis, while the latter is
an important modulator in the pathophysiology of neuro-
nal damage [8]. The activated urokinase converts pro-
enzyme, plasminogen into plasmin, a serine protease
involved in the ECM destruction by degrading fibrin. In
this study, the zymographic assays revealed that both ser-
ine and metalloproteases from AGE isolate degraded plas-
minogen at neutral pH (Fig. 5).
The metalloprotease activity can be separated from the 
serine protease activity by ion exchange chromatography
In an attempt to obtain purified metalloprotease, FPLC
ion-exchange chromatography was employed. The chro-
matograms in Fig. 6 show at least two major peaks and the
corresponding column fractions exhibited protease activ-
ity. The eluted protein(s) in the first peak (fractions 10
and 11) contained metalloprotease activity (approx. Mw.
150 KD) (Fig. 6), separated apparently from the serine
protease and sensitive to 1, 10-phenanthroline on gelatin
gel zymography (data not shown). Of interest, the serine
protease was observed in later fractions (data not shown).
Discussion
Acanthamoeba  granulomatous encephalitis is a serious
CNS infection that almost always results in death. The
pathophysiological complications involving the CNS
most likely include invasion of the connective tissue,
induction of extensive pro-inflammatory responses and
neuronal damage leading to brain dysfunction. Thus it is
reasonable to predict that Acanthamoeba  proteases play
important roles in AGE pathogenesis. Our previous stud-
ies have shown that Acanthamoeba  proteases may play
important roles in modulating blood-brain barrier perme-
ability [9]. In this study, we further characterized Acan-
thamoeba proteases from an AGE isolate and developed
methods to separate an extracellular metalloprotease
from the extracellular serine protease.
The fact that a 150 KD extracellular metalloprotease is
associated with an AGE isolate (and not keratitis isolate)
suggests its possible involvement in the CNS pathology.
To this end, we studied the properties of AGE isolate pro-
teases on ECM degradation. In healthy brains, ECM com-
prises a major percent of the normal brain volume [10],
which forms the basal lamina around the blood vessels.
The ECM is constantly remodelled and provides critical
structural and functional support to the neuronal tissue.
These properties of ECM are tightly regulated by a family
of mostly Ca2+-dependent Zn2+-containing endopepti-
dases (MMPs) [11,12]. The ECM plays important roles
under normal physiological conditions in the develop-
ment and maintenance of homeostasis in neuronal tissue.
However in neurological disease states, ECM may
undergo substantial modifications resulting in neuroin-
flammatory responses. Excessive ECM degradation affects
neurovascular structural/functional properties that are
highly destructive to the CNS functions. ECM is com-
posed of both collagenous and non-collagenous glyco-
proteins and proteoglycans [11,12]. Here we showed that
both the serine and metalloproteases of the AGE isolate
exhibits collagen I and collagen III degradation suggesting
that these proteases may facilitate amoebic migration into
deeper tissues by degrading the ECM. These findings sup-
port previous findings which showed that Acanthamoeba
Acanthamoeba (AGE isolate belonging to T1 genotype) pro- teases exhibit optimal activities at neutral pH Figure 3
Acanthamoeba (AGE isolate belonging to T1 geno-
type) proteases exhibit optimal activities at neutral 
pH. To determine the effects of pH, zymographic assays 
were performed as described in the "Materials and Methods" 
and gels incubated at various pHs. Note that neutral pH pro-
duced optimal proteolytic activities. Results are representa-
tive of three independent experiments. Each lane contained 
0.5 µg protein.BMC Microbiology 2006, 6:42 http://www.biomedcentral.com/1471-2180/6/42
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exhibit collagenolytic activities [13]. Furthermore, both
proteases exhibited elastinolytic activities. Elastin is the
principal structural element that constitutes elastic fibres
and is an important component of connective tissue. Pre-
vious findings have shown that elastase destroys ECM,
which increases blood-brain barrier permeability result-
ing in the brain injury [14-16]. For example, injection of
elastase into the cerebrospinal fluid (CSF) opened the
blood-brain barrier in newborn piglets [17]. Our findings
suggest that proteases of AGE isolate may play a similar
role.
In addition to the aforementioned, the urokinase plas-
minogen activator system plays an important role in vari-
ous neuronal diseases involving the CNS inflammation
and/or pathology. For example, in bacterial meningitis,
the uPA (urokinase-type plasminogen activator) or tPA
(tissue-type plasminogen activator) are known to convert
plasminogen, that is abundant in brain [18] into plasmin,
which destroys ECM directly by degrading fibrin or by
activating MMPs. We observed that both serine and met-
alloproteases directly degraded pro-enzyme, plasminogen
suggesting that pathogenesis of AGE may involve the uPA/
tPA system. Injections of plasmin results in increased cap-
illary permeability [19]. At present, the precise role of the
150 KD metalloproteases remains unclear.
Our findings that CM-mediated HBMEC monolayer dis-
ruptions can be inhibited in the presence of PMSF suggest
that the metalloprotease may not be responsible for
HBMEC monolayer disruptions and may play a role in
post-CNS invasion by amoebae. To this end, we have suc-
cessfully developed methods for the separation of the
metalloprotease from the serine protease of the AGE iso-
late, which should prove useful for subsequent purifica-
tion and biochemical characterizations of this novel
protease as well as to determine its role in vivo.
It is important to note that we only observed two pro-
teases in our zymographic assays. However, the experi-
mental conditions involved SDS detergent and there may
be other proteases that are SDS-sensitive. Also, the identi-
fication of 130 KD serine protease is not novel. Previous
studies have characterized a similar protease from an AK
isolates [20-22] and again in the present study we
observed 130 KD serine protease from an AK isolate
belonging to T4 genotype. Thus it is reasonable to pre-
sume that the 130 KD serine protease is similar in both T1
and T4 isolates. Taken together, these studies have charac-
terized the properties of a novel metalloprotease that only
is produced by the AGE isolate. Future studies will precise
determine its role in the virulence of AGE. Of interest,
metalloproteases have been identified as important viru-
lence factors in various opportunistic pathogens including
Vibrio vulnificus [23],  Pseudomonas aeruginosa [24], and
Aspergillus fumigatus [25].
Conclusion
In summary, these data show that both serine and metal-
loproteases secreted by AGE isolate (T1 genotype), exhibit
properties to degrade ECM, which may facilitate amoebic
invasion of the deeper lying tissues of the CNS. If future
studies confirm that these proteases are indeed important
in the pathology of AGE then they could be potential tar-
gets for the rationale development of therapeutic inter-
ventions.
Methods
All chemicals were purchased from Sigma (Poole, Dorset,
UK), unless otherwise stated.
Acanthamoeba (AGE isolate belonging to T1 genotype) pro- teases exhibit optimal activities at various temperatures Figure 4
Acanthamoeba (AGE isolate belonging to T1 geno-
type) proteases exhibit optimal activities at various 
temperatures. To determine the effects of variable tem-
peratures, zymographic assays were performed as described 
in the "Materials and Methods" and gels incubated at various 
temperatures. Note that 37 – 50°C produced optimal prote-
olytic activities. Results are representative of three independ-
ent experiments. Each lane contained 0.5 µg protein.BMC Microbiology 2006, 6:42 http://www.biomedcentral.com/1471-2180/6/42
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Acanthamoeba cultures
Two isolates of Acanthamoeba were used in the present
study: 1) A. castellanii (ATCC 50494) belonging to T1 gen-
otype was isolated from an AGE patient, and 2) A. castel-
lanii (ATCC 50492)belonging to T4 genotype was isolated
from a keratitis patient. For simplicity, the former is
referred to as the AGE isolate and the latter is referred to
as the AK isolate. Both isolates were grown in tissue cul-
ture flasks in PYG medium [proteose peptone 0.75% (w/
v), yeast extract 0.75% (w/v) and glucose 1.5% (w/v)] at
30°C and the medium was refreshed 17–20 h prior to
experiments as previously described [26]. This resulted in
>95% Acanthamoeba in the trophozoite forms.
Human brain microvascular endothelial cell cultures
The primary brain microvascular endothelial cells were
isolated from human tissue and purified by fluorescent
activated cell sorting (FACS). The purified cells were tested
for endothelial characteristics, such as expression of
endothelial markers, F-VIII, carbonic anhydrase IV and
uptake of acetylated low density lipoprotein (AcLDL),
indicating their endothelial origin and expression of
gamma-glutamyl transpeptidase, indicating the brain ori-
gin (27). HBMEC were grown in RPMI-1640 containing
10% foetal bovine serum, 10% NuSerum, 2 mM
glutamine, 1 mM pyruvate, penicillin (100 U/ml), strep-
tomycin (100 U/ml), non-essential amino acids and vita-
mins at 37°C, 5% CO2 as previously described [27,28].
Cytotoxicity assays
To examine the cytopathic potential of Acanthamoeba iso-
lates, cytotoxicity assays were performed as previously
described [26]. Briefly, HBMEC were grown to confluent
monolayers in 24-well plates. Acanthamoeba  (5 × 105
amoebae/well) were incubated with HBMEC monolayers
in serum free medium (RPMI 1640 containing 2 mM
glutamine, 1 mM pyruate and non-essential amino acids)
in plates incubated at 37°C in 5% CO2. The HBMEC
monolayers were observed periodically under a phase-
contrast microscope for cytopathic effects for up to 24 h.
After 24 h, the supernatants (termed conditioned
medium, CM) were collected, and the monolayers were
fixed and stained with hematoxylin to visualize HBMEC
monolayer disruptions. In addition, supernatants were
examined for HBMEC cytotoxicity by measuring lactate
dehydrogenase (LDH) release (cytotoxicity detection kit;
Roche Applied Science, Lewes, East Sussex, UK). Briefly,
CM of co-cultures of Acanthamoeba  and HBMEC were
assessed for the presence of LDH, the release of which is
considered as an estimate of cell death. The percentage
LDH release was calculated as follows: [LDH activity in
experimental sample (measured by optical density at 590
nm) - LDH activity in control samples/total LDH activity
release - LDH activity in control samples × 100 = % cyto-
toxicity). Control samples were obtained from HBMEC or
Acanthamoeba incubated alone. Total LDH activity release
was determined by total HBMEC lysis with 1% Triton X-
100 for 30 min at 37°C.
To determine the cytopathic effects of extracellular pro-
teases released from intact Acanthamoeba, CM was pro-
duced by inoculating Acanthamoeba in serum free medium
described above for 24 h. Next day, Acanthamoeba free
supernatants, i.e., CM was collected by centrifugation and
used for cytotoxicity assays as described above.
Some cytotoxicity assays were performed in the presence
or absence of broad spectrum matrix metalloprotease
(MMP) inhibitors, i.e., GM 6001 and GM 1489 (Merck
Acanthamoeba (T1) proteases degrade various protein sub- strates including extracellular matrix (ECM) Figure 5
Acanthamoeba (T1) proteases degrade various pro-
tein substrates including extracellular matrix (ECM). 
Zymographic assays were performed using various substrates 
that constitute ECM or involved in ECM degradation. Note 
that proteases of AGE isolate degraded collagen I (A), colla-
gen III (B), elastin (C) and plasminogen (F). In addition, both 
proteases degraded gelatin (D), casein (E) and haemoglobin 
(G). CM is conditioned medium plus or minus the serine 
protease inhibitor, PMSF. Results are representative of three 
independent experiments.BMC Microbiology 2006, 6:42 http://www.biomedcentral.com/1471-2180/6/42
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Biosciences Ltd. Nottingham, England) or phenylmeth-
anesulfonyl fluoride (PMSF), an irreversible inhibitor of
serine proteases. Briefly, the protease inhibitors (PMSF, 2
mM final conc.; GM 6001 and GM 1489, 5 µM final conc.)
were added to CM for 30 min and then mixtures were
added to HBMEC monolayers.
Zymography
Zymographic assays were performed to visualize and
begin to characterize Acanthamoeba extracellular proteases
as previously described [29]. Briefly, CM was mixed (1:1)
with sample buffer (containing 4% sodium dodecyl sul-
fate (SDS) but without β-mercaptoethanol) and electro-
phoresed on SDS-polyacrylamide gels (SDS-PAGE)
containing gelatin (1 mg/mL). After electrophoresis, gels
were soaked in 2.5% Triton X-100 (w/v) for 60 min to
remove the SDS. Finally, the gels were incubated in a
developing buffer (50 mM Tris-HCl, pH 7.5, containing
10 mM CaCl2) at 37°C overnight, rinsed, and stained
with Coomassie brilliant blue. Areas of gelatin digestion
indicating protease activities are seen as non-staining
regions in the gel. In some experiments, samples were pre-
treated with PMSF (2 mM final concentration), or 1, 10-
phenanthroline (10 mM final concentration) for 30 min.
Because 1, 10-phenanthroline is a reversible inhibitor, it
was also included in the developing buffer.
To determine the optimum temperature for Acanthamoeba
protease activities, gels were incubated at 4°C, 10°C,
20°C, 30°C, 37°C, 42°C, 50°C and 65°C. For the deter-
mination of optimum pH, gels were incubated at pH rang-
ing from 3 – 13. For pH 3 and 4, developing buffers were
prepared using citrate-phosphate buffer (70 mM sodium
citrate and 60 mM sodium phosphate) containing 10 mM
CaCl2; for pH 5 and 6, developing buffers were prepared
using N- [2-morpholino] ethanesulfonic acid (MES) con-
taining 10 mM CaCl2; and for pH 7 – 13, developing buff-
ers were prepared using 50 mM Tris containing 10 mM
CaCl2.
In some experiments, we used extracellular matrix (ECM)
proteins including collagen I (obtained from bovine
achilles tendon; 1 mg/mL final conc.) dissolved in buffer
A (50 nM TES {N-tris [hydroxymethyl]methyl-2-ami-
noethane-sulfonic acid}, pH 7.4 plus 0.36 mM CaCl2),
collagen III (calf skin; 1 mg/mL final conc.) dissolved in
buffer B (distilled H2O, pH 3 using acetic acid), elastin
(bovine neck ligament; 1 mg/mL final conc.) dissolved in
buffer C (200 mM Tris, pH 8.8) and plasminogen (rabbit
plasma; 1 mg/mL final conc.) dissolved in buffer D (20
mM lysine, pH 7) as substrate for Acanthamoeba proteases.
In addition we used casein (bovine milk; 1 mg/mL final
conc.) dissolved in buffer E (60 mM Tris, 90 mM NaCl,
pH7.5) and haemoglobin (bovine erthyrocytes; 1 mg/mL
final conc.) dissolved in distilled H2O with gentle heat as
substrate for Acanthamoeba proteases. All substrates were
dissolved according to manufacturer's instructions (i.e.,
Sigma Labs).
Ammonium sulphate precipitation
In an attempt to purify extracellular proteases of Acan-
thamoeba, (ca. 500 mL), CM was produced and proteins
precipitated by adding ammonium sulphate (0.7 g/mL)
slowly to the CM while stirring at 4°C to achieve 70% sat-
uration. The mixture was stirred for an additional 25 min.
The precipitate was recovered by centrifugation (10,000 ×
g for 10 min at 4°C) and dissolved in 500 µl of 0.02 M
ammonium acetate buffer, pH 6.5. The concentrated pro-
Separation of metalloprotease by ion-exchange chromatogra- phy Figure 6
Separation of metalloprotease by ion-exchange chro-
matography. Proteins in CM from the AGE isolate were 
precipitated and fractionated using FPLC ion-exchange chro-
matography. A) A representative chromatogram showing a 
typical elution profile is shown. The collected fractions were 
tested for protease activity, and B) shows that fractions 10 
and 11 (in the first major UV-absorbing peak) exhibited only 
metalloprotease activity (approx. Mw. 150 KD). Results are 
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teins were dialysed against HPLC grade H2O overnight to
remove residual ammonium sulphate.
Ion-exchange chromatography
The dialysed precipitated proteins were applied to a
DEAE-Sepharose fast flow beads column (16 cm length, 2
cm diameter) (Amersham Biosciences). The column was
equiliberated with 100 mL of 0.02 M ammonium acetate
buffer, pH 6.5 at a flow rate of 4 mL per min. Using a fast
performance liquid chromatography system (Biorad,
Hemel Hempstead, UK), proteins were eluted in 0.02 M
ammonium acetate with a 0 to 1.0 M NaCl gradient. Pro-
teins in the eluted fractions (6 mL) were freeze dried for
long term storage. The lyophilised fractions were reconsti-
tuted in 1 mL of 50 mM Tris-HCl, pH 6.8 and tested for
protease activities using zymographic assays.
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